Literature DB >> 2803950

Anti-inflammation induced by counter-irritation or by treatment with non-steroidal agents inhibits the growth of a tumour of non-detected immunogenicity.

D O Sordelli1, P A Fontán, R P Meiss, R A Ruggiero, O D Bustuoabad.   

Abstract

Counter-irritation (CI) triggered by different non-specific irritant stimuli delayed the growth of a murine tumour of non-detected immunogenicity. The syngeneic LB tumour transplant by itself also induced CI and decreased the number of leukocytes migrating to a secondary s.c. irritant stimulus, e.g. sponge or carrageenan. On the other hand, partial inhibition of cell migration by treatment with either 0.5 mg kg-1 indomethacin or 0.3 mg kg-1 piroxicam retarded LB tumour growth, presumably by a mechanism unrelated to inhibition of immune responses by PGE2. It is suggested that CI may play a role in the early stages of concomitant resistance.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2803950      PMCID: PMC2247308          DOI: 10.1038/bjc.1989.349

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  37 in total

Review 1.  The anti-inflammatory activity of irritants.

Authors:  D C Atkinson; R Hicks
Journal:  Agents Actions       Date:  1975-08

2.  On the mechanism of tumor "concomitant immunity".

Authors:  E Gorelik; S Segal; M Feldman
Journal:  Int J Cancer       Date:  1981-06-15       Impact factor: 7.396

3.  Antileukocyte activity I. Systemic inhibition of cellular emigration following local inflammation.

Authors:  S J Normann; M Schardt; E Sorkin
Journal:  J Leukoc Biol       Date:  1985-03       Impact factor: 4.962

4.  Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine.

Authors:  M Pollard; P H Luckert
Journal:  Science       Date:  1981-10-30       Impact factor: 47.728

5.  Regression of head and neck carcinoma with a prostaglandin-synthesis inhibitor.

Authors:  W R Panje
Journal:  Arch Otolaryngol       Date:  1981-11

6.  Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment.

Authors:  T Narisawa; M Sato; M Tani; T Kudo; T Takahashi; A Goto
Journal:  Cancer Res       Date:  1981-05       Impact factor: 12.701

7.  "Concomitant immunity" in murine tumours of non-detectable immunogenicity.

Authors:  R A Ruggiero; O D Bustuoabad; R D Bonfil; R P Meiss; C D Pasqualini
Journal:  Br J Cancer       Date:  1985-01       Impact factor: 7.640

8.  Mechanism of inhibition of tumour growth by aspirin and indomethacin.

Authors:  N R Lynch; M Castes; M Astoin; J C Salomon
Journal:  Br J Cancer       Date:  1978-10       Impact factor: 7.640

9.  Increased survival of cancer-bearing mice treated with inhibitors of prostaglandin synthesis alone or with chemotherapy.

Authors:  A Bennett; D A Berstock; M A Carroll
Journal:  Br J Cancer       Date:  1982-05       Impact factor: 7.640

10.  Effects of cimetidine and indomethacin on the growth of dimethylhydrazine-induced or transplanted intestinal cancers in the rat.

Authors:  A Caignard; M Martin; D Reisser; B Thomas; F Martin
Journal:  Br J Cancer       Date:  1984-11       Impact factor: 7.640

View more
  4 in total

1.  Kaurenic acid: An in vivo experimental study of its anti-inflammatory and antipyretic effects.

Authors:  Miriam C Sosa-Sequera; Omar Suárez; Nelson L Daló
Journal:  Indian J Pharmacol       Date:  2010-10       Impact factor: 1.200

2.  Piroxicam-copper complexes: inhibition of polymorphonuclear leukocyte migration to Pseudomonas aeruginosa chemotactins in vivo and superoxide dismutase-like activity in vitro.

Authors:  D O Sordelli; P A Fontán; C R Amura
Journal:  Agents Actions       Date:  1993-03

3.  A theoretical explanation of "concomitant resistance".

Authors:  S Michelson; J T Leith
Journal:  Bull Math Biol       Date:  1995-09       Impact factor: 1.758

4.  Treatment with a non-steroidal anti-inflammatory agent delays the growth of spontaneous pulmonary metastases of a mammary adenocarcinoma of non-detected immunogenicity.

Authors:  P A Fontán; C R Amura; D O Sordelli
Journal:  Br J Cancer       Date:  1992-11       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.